SANGAMO THERAPEUTICS INC

SGMOQ

0.07113.34% ( +0.0023 )

Delay Closed: Jul 30, 16:00:00 (EDT)

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: SANGAMO THERAPEUTICS INC(SGMOQ) predict that the Revenue is 1.442 M (-77.6%), Miss estimate;the EBIT is -31.95 M (-7.82%), Miss estimate;the EPS is -0.08 (+42.86%), Miss estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueMiss expectations

0.00B77.60%

0.01B80.73%

-0.01B158.33%

EBITMiss expectations

-0.03B7.82%

-0.02B17.87%

-0.01B25.69%

EPSMiss expectations

-0.0842.86%

0.0367126.19%

-0.116783.33%

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD